Takashi Kei Kishimoto's most recent trade in Selecta Biosciences Inc was a trade of 43,000 Common Stock done . Disclosure was reported to the exchange on May 30, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2023 | 43,000 | 321,316 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2023 | 43,000 | 278,316 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2023 | 26,500 | 225,316 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 May 2023 | 26,500 | 251,816 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 6,381 | 367,719 (0%) | 0% | 1.1 | 7,234 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 3,372 | 364,336 (0%) | 0% | 1.1 | 3,808 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 04 Jan 2023 | 20 | 364,316 (0%) | 0% | 1.1 | 22 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 04 Jan 2023 | 11 | 367,708 (0%) | 0% | 1.2 | 13 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 475,000 | 475,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 100,000 | 374,100 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.09 per share. | 05 Jan 2022 | 3,416 | 268,353 (0%) | 0% | 3.1 | 10,541 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 340,000 | 340,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 72,000 | 271,769 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 10 Dec 2021 | 4,370 | 199,769 (0%) | 0% | 3.0 | 13,053 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 13,750 | 204,139 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 13 Oct 2021 | 3,892 | 190,389 (0%) | 0% | 4.4 | 17,086 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 13,750 | 194,281 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 13,629 | 0 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.77 per share. | 07 May 2021 | 13,629 | 177,778 (0%) | 0% | 2.8 | 37,752 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 230,000 | 230,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 38,000 | 164,149 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.77 per share. | 23 Oct 2020 | 30,000 | 126,149 (0%) | 0% | 2.8 | 83,100 | Common Stock |
| Selecta Biosciences Inc | Takashi Kei Kishimoto | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 30,000 | 13,629 | - | - | Employee Stock Option (right to buy) |